㈜중헌제약

{
  "address": "서울특별시 영등포구",
  "ceo_name": "윤석준",
  "certificate": [
    {
      "cert_number": "20160400810",
      "changes": "",
      "disclosure_date": "2016-05-27",
      "first_cert_date": "2016-05-27",
      "no": "1",
      "type": "연구개발유형",
      "valid_period": "2016-05-27 ~ 2018-05-26"
    },
    {
      "cert_number": "20180401469",
      "changes": "",
      "disclosure_date": "2018-06-19",
      "first_cert_date": "2016-05-27",
      "no": "2",
      "type": "연구개발유형",
      "valid_period": "2018-05-27 ~ 2020-05-26"
    },
    {
      "cert_number": "20200401775",
      "changes": "",
      "disclosure_date": "2020-07-29",
      "first_cert_date": "2016-05-27",
      "no": "3",
      "type": "연구개발유형",
      "valid_period": "2020-05-27 ~ 2022-05-26"
    },
    {
      "cert_number": "20220728020004",
      "changes": "",
      "disclosure_date": "2022-07-28",
      "first_cert_date": "2016-05-27",
      "no": "4",
      "type": "연구개발유형",
      "valid_period": "2022-05-27 ~ 2025-05-26"
    },
    {
      "cert_number": "20250723020023",
      "changes": "",
      "disclosure_date": "2025-07-23",
      "first_cert_date": "2016-05-27",
      "no": "5",
      "type": "연구개발유형",
      "valid_period": "2025-05-27 ~ 2028-05-26"
    }
  ],
  "company_name": "㈜중헌제약",
  "corp_no": "150111-*******",
  "financials": {
    "2022": {
      "capital_stock": 10870264000,
      "cost_of_sales": 8054579000,
      "current_assets": 14898279000,
      "current_liabilities": 14175871000,
      "gross_profit": 10463956000,
      "net_income": 1637325000,
      "net_income_bs": 1500707000,
      "non_current_assets": 17334769000,
      "non_current_liabilities": 9224164000,
      "non_operating_expenses": 923419000,
      "non_operating_income": 133408000,
      "operating_profit": 2427336000,
      "revenue": 18518535000,
      "sga_expenses": 8036620000,
      "total_assets": 32233048000,
      "total_equity": 8833013000,
      "total_liabilities": 23400035000
    },
    "2023": {
      "capital_stock": 10870265000,
      "cost_of_sales": 8246416000,
      "current_assets": 17086392000,
      "current_liabilities": 16224924000,
      "gross_profit": 11793206000,
      "net_income": 1375160000,
      "net_income_bs": 1297796000,
      "non_current_assets": 17158846000,
      "non_current_liabilities": 7883838000,
      "non_operating_expenses": 1266624000,
      "non_operating_income": 134118000,
      "operating_profit": 2507666000,
      "revenue": 20039622000,
      "sga_expenses": 9285540000,
      "total_assets": 34245238000,
      "total_equity": 10136476000,
      "total_liabilities": 24108762000
    },
    "2024": {
      "capital_stock": 10870265000,
      "cost_of_sales": 7574348000,
      "current_assets": 19950246000,
      "current_liabilities": 18932900000,
      "gross_profit": 12521238000,
      "net_income": 1635913000,
      "net_income_bs": 1456627000,
      "non_current_assets": 17244493000,
      "non_current_liabilities": 6668736000,
      "non_operating_expenses": 1243718000,
      "non_operating_income": 127963000,
      "operating_profit": 2751668000,
      "revenue": 20095586000,
      "sga_expenses": 9769570000,
      "total_assets": 37194739000,
      "total_equity": 11593103000,
      "total_liabilities": 25601636000
    }
  },
  "industry": "합성의약품 및 기타 완제 의약품 제조업",
  "investment": [],
  "main_products": "아데노피주, 프리번정",
  "phone": "02-6928-****",
  "years": [
    2024,
    2023,
    2022
  ]
}